André P. Fay, MD, PhD Professor, PUCRS School of Medicine Chief, Medical Oncology Department – Hospital São Lucas da PUCRS/…
Browsing: Kidney
Samra Turajlic BA, MBBS, MRCP, PhD, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust, London Cancer Research UK Clinician Scientist,…
E. Jason Abel MD, FACS University of Wisconsin discusses Cytoreductive nephrectomy Placing recent clinical trials in context at the Seventeenth…
Michael A.S. Jewett DEPARTMENT OF SURGICAL ONCOLOGY PRINCESS MARGARET CANCER CENTRE DIVISION OF UROLOGY THE UNIVERSITY OF TORONTO discusses Heterogeneity…
Kimberly Allman, MSN, CNP Cleveland Clinic Taussig Cancer Institute discusses Ipilimumab plus Nivolumab as Salvage Therapy in Patients with Checkpoint…
Ritesh Kotecha discusses Second-Line VEGFR TKI Outcomes After First-Line Immune Checkpoint Blockade in Metastatic Renal Cell Carcinoma at the Seventeenth…
Neeraj Agarwal Huntsman Cancer Center discusses Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:?Results of the dose-escalation stage…
Andrey Soares Medical Oncologist Centro Paulista de Oncologia and Hospital Israelita Albert Einstein SPChair LACOG GU gives an UPDATES LATIN…
Rodolfo Borges dos Reis, MD, PhD Uro-oncology Ribeirao Preto Medical School discusses LARCG Latin American Renal Cancer Group at the…
Alberto Diaz de Leon M.D. discusses Whole Body MRI for Detection of Renal Cell Carcinoma Osseous Metastases at the Seventeenth…
Abhishek A. Chakraborty Instructor in Medicine Department of Medical Oncology Laboratory of William Kaelin Dana-Farber Cancer Institute Harvard Medical School…
Kathleen Mahoney, M.D., Ph.D. Instructor of Medicine, Harvard Medical School Attending, Beth Israel Deaconess Medical Center Research Fellow, Dana Farber…
A Ari Hakimi MD Assistant Member, Department of Surgery, Urology Service Member, Immunogenomics and Precision Oncology Platform discusses the Novel…
Toni K. Choueiri, MD Director, Lank Center for Genitourinary Oncology Department of Medical Oncology Dana-Farber Cancer Institute discusses Neovax: From…
Thai H. Ho, MD, PhD Mayo Clinic Arizona discusses Targeting Epigenetics and Chromatin Remodeling Genes From the Seventeenth International Kidney…
Thomas Powles Director of Barts Cancer Centre discusses The next therapeutic targets: TGFbeta From the Seventeenth International Kidney Cancer International…
Abhishek Tripathi MD Assistant Professor of Medicine University of Oklahoma Stephenson Cancer Center discusses Adenosine Pathway Inhibitors From the Seventeenth…
Ranjit S. Bindra, M.D., Ph.D. Associate Professor Departments of Therapeutic Radiology and Experimental Pathology Yale Cancer Center discusses Exploiting oncometabolite-induced…
Suzanne Cole, MD FACP Medical Director, Community Cancer Clinic Richardson Plano UT Southwestern Medical Center discusses Engaging Clinical Trialists in…
Robert G. Uzzo, M.D. Willing G. Pepper Chairman of Surgery Fox Chase Cancer Center Temple University School of Medicine Chair,…
Hyung L. Kim, M.D. Director, Academic Urology Programs Cedars Sinai Medical Center discusses What is the Next Cytoreductive Surgical Trial?…
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology MD Anderson Cancer Center discusses Combination…
Phillip M. Pierorazio, MD Associate Professor of Urology and Oncology Brady Urological Institute, Department of Urology? Johns Hopkins Medicine, Baltimore,…
Dr. Andrew W. Silagy Urologic Oncology Research Fellow Memorial Sloan Kettering Cancer Center discusses An Evaluation of the Role of…
Nizar M. Tannir University of Texas MD Anderson Cancer Center, Houston, TX, USA discusses CheckMate 214 Retrospective Analyses From the…
Nieves Martinez Chanza Department of Oncology, Jules-Bordet Institute, Free University of Brussels (Belgium) discusses Safety and efficacy of checkpoint inhibitors…
Tian Zhang, MD Assistant Professor of Medicine Duke Cancer Institute discusses PDIGREE From the Seventeenth International Kidney Cancer International Symposium…
Thomas Powles Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, Royal Free NHS Trust, London, UK…
Rana R. McKay, MD Assistant Professor of Medicine UC San Diego discusses Rationally Targeting the Bone with Radium Plus Cabozantinib…
Matt Campbell MD Assistant Professor GU Medical Oncology UT MD Anderson Cancer Center discusses Ongoing Clinical Trial Update: A Pilot…
Moshe C. Ornstein MD MA, Laura S. Wood RN MSN OCN, Kimberly Allman MSN CNP, Allison Martin PA-C Timothy Gilligan…
Hans Hammers MD, PhD Associate Professor of Internal Medicine in the Division of Hematology-Oncology at UT Southwestern Medical Center discusses…
Charles G. Drake MD / PhD Director GU Medical Oncology Co-Director: Immunotherapy Program Associate Director for Clinical Research Professor of…
Primo N Lara, Jr., MD Director, University of California Davis Comprehensive Cancer Center Professor of Medicine and Executive Associate Dean…
Michael B. Atkins, M.D. William M. Scholl Professor and Vice Chair Department of Oncology Deputy Director Georgetown-Lombardi Comprehensive Cancer Center…
Ewelina Morawa, MD Executive Medical Director CRISPR Therapeutics discusses Allogeneic Anti-CD70 CAR T Cells ?for Renal Cell Carcinoma From the…
Steven L. Chang, MD, MS Assistant Professor of Surgery, Harvard Medical School Surgical Oncologist, Dana-Farber Cancer Institute Associate Surgeon, Division…
Alexander Kutikov, MD, FACS Professor and Chief, Urologic Oncology Fox Chase Cancer Center, Philadelphia, PA discusses Enucleation of Renal Mass:…
Gopal N. Gupta, MD, FACS Associate Professor Departments of Urology, Surgery and Radiology Cardinal Bernardin Cancer Center Loyola University Health…
Steven S. Raman, MD FSAR FSIR Professor of Radiology, Urology and Surgery Division of Abdominal Imaging & Intervention Departments of…
John Leppert, MD MS Associate Professor Stanford University Director of Urologic Oncology, VA Palo Alto discusses Overdiagnosis and the Harms…
Timothy McClure, MD Assistant Professor of Urology Assistant Professor of Interventional Radiology Weill Cornell Medicine discusses Emerging Ablative Technologies -…
Jaime Landman Professor of Urology and Radiology Chairman, Department of Urology UCI discusses Renal mass biopsy in 2018: When, where…
David Braun, MD, PhD, Dana-Farber Cancer Institute discusses Single Cell RNA-Sequencing in RCC from the Seventeenth International Kidney Cancer International…
Dr. Lisa Derosa, MD PhD Candidate Immunoncology – Pr. L. Zitvogel discusses The impact of the stool microbiome in RCC…
James Brugarolas, M.D., Ph.D. Director, Kidney Cancer Program Principal Investigator, UT Southwestern Kidney Cancer SPORE Sherry Wigley Crow Endowed Chair…
James J. Hsieh MD PhD Professor, Molecular Oncology, Siteman Cancer Center, Washington University in St. Louis discusses RCC Profiling from…
Neeraj Agarwal, MD Professor of Medicine Huntsman Cancer Institute (HCI) Presidential Endowed Chair of Cancer Research Co-Leader, HCI Experimental Therapeutics…
Viraj Master MD PhD FACS Professor Associate Chair for Clinical Affairs and Quality Director of Clinical Research Unit Department of…
Robert Motzer MD, board-certified medical oncologist of Memorial Sloan Kettering Cancer Center, discusses Progress In Advanced Kidney Cancer Treatment At…